Ro 18-0647/002; (–)-Tetrahydrolipstatin; N-formyl-L-leucine-(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
96829-58-2
495.7
C29H53NO5
DMF, DMSO, Ethanol
-20°C
Orlistat is a DAG Lipase-α inhibitor. Orlistat is a medication to treat research obesity. Function is preventing the absorption of fats from the Human diet. Anti-obesity reagent.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
